Healthcare Market Research Reports and Trends

The increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination are expected to drive the growth of this market. The global market is segmented by product, technique, application, end user, and region. By product, the market is segmented into kits & reagent, services, and instruments. The kits & reagent segment is expected to lead the global market in 2017. The frequent purchase of these consumables as compared to instruments and increasing use of kit-based techniques are the key factors driving the growth of this segment. The  mycoplasma testing market  is segmented into cell line testing, virus testing, end-of-production cell testing, and other applications. Cell line testing segment accounts for the largest segment and is also the fastest growing application segment in the market. Increasing use of cell lines for research and biopharmaceu...

The increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination are expected to drive the growth of this market. The global market is segmented by product, technique, application, end user, and region. By product, the market is segmented into kits & reagent, services, and instruments. The kits & reagent segment is expected to lead the global market in 2017. The frequent purchase of these consumables as compared to instruments and increasing use of kit-based techniques are the key factors driving the growth of this segment. On the basis of technique, the market is classified into PCR, ELISA, direct assays, indirect assays, DNA staining, microbial culture techniques, and enzymatic methods. The PCR segment is expected to account for the largest share of the market in 2017 due it the high acceptance rate of PCR, which can be attributed to its accuracy, speed...

The global market is segmented by product, technique, application, end user, and region. By product, the market is segmented into kits & reagent, services, and instruments. The kits & reagent segment is expected to lead the global  mycoplasma testing market  in 2017. The frequent purchase of these consumables as compared to instruments and increasing use of kit-based techniques are the key factors driving the growth of this segment. Based on technique, the market is classified into PCR, ELISA, direct assays, indirect assays, DNA staining, microbial culture techniques, and enzymatic methods. The PCR segment is expected to account for the largest share of the market in 2017 due it the high acceptance rate of PCR, which can be attributed to its accuracy, speed, and flexibility in life sciences research. Sample Report -  https://www.marketsandmarkets.com/requestsampleNew.asp?id=136509856 Based on application, the mycoplasma testing market is segmented into cel...